AU4169897A - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
AU4169897A
AU4169897A AU41698/97A AU4169897A AU4169897A AU 4169897 A AU4169897 A AU 4169897A AU 41698/97 A AU41698/97 A AU 41698/97A AU 4169897 A AU4169897 A AU 4169897A AU 4169897 A AU4169897 A AU 4169897A
Authority
AU
Australia
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41698/97A
Inventor
Cora S. Grossman
Joseph M. Gruber
Chuan Shih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Hawaii
Wayne State University
Eli Lilly and Co
Original Assignee
University of Hawaii
Wayne State University
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Hawaii, Wayne State University, Eli Lilly and Co filed Critical University of Hawaii
Publication of AU4169897A publication Critical patent/AU4169897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU41698/97A 1996-08-30 1997-08-28 Pharmaceutical compounds Abandoned AU4169897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2507896P 1996-08-30 1996-08-30
US60025078 1996-08-30
PCT/US1997/015236 WO1998008829A1 (en) 1996-08-30 1997-08-28 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
AU4169897A true AU4169897A (en) 1998-03-19

Family

ID=21823932

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41698/97A Abandoned AU4169897A (en) 1996-08-30 1997-08-28 Pharmaceutical compounds

Country Status (5)

Country Link
EP (1) EP0923564A4 (en)
JP (1) JP2001500853A (en)
AU (1) AU4169897A (en)
CA (1) CA2264297A1 (en)
WO (1) WO1998008829A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2241086A1 (en) * 1995-12-22 1997-07-03 University Of Hawai'i Pharmaceutical compounds
JP2001500484A (en) * 1996-08-30 2001-01-16 イーライ・リリー・アンド・カンパニー Method for producing pharmaceutical compounds
JP2001506970A (en) * 1996-09-06 2001-05-29 イーライ・リリー・アンド・カンパニー Methods and novel intermediates
NZ336918A (en) * 1997-02-26 2001-11-30 Lilly Co Eli Selective epoxidation process for preparing pharmaceutical compounds comprising Cryptophycin 52
US6103913A (en) * 1998-10-16 2000-08-15 Eli Lilly And Company Process for preparing enollactone derivatives
US6376230B1 (en) 1998-10-16 2002-04-23 Eli Lilly And Company Stereoselective process for producing intermediates of cryptophycins
DE19913995A1 (en) 1999-03-29 2000-10-05 Basf Ag Process for the preparation of granular N-alkylamonium acetonitrile salts
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946835A (en) * 1988-07-15 1990-08-07 Merck & Co., Inc. Antifungal fermentation product and method
US4845086A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845085A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent

Also Published As

Publication number Publication date
WO1998008829A1 (en) 1998-03-05
EP0923564A4 (en) 1999-12-08
CA2264297A1 (en) 1998-03-05
JP2001500853A (en) 2001-01-23
EP0923564A1 (en) 1999-06-23

Similar Documents

Publication Publication Date Title
GB9602080D0 (en) Pharmaceutical compounds
AU4762797A (en) Pharmaceutical compositions
AU6740298A (en) Pharmaceutical composition
AU2967597A (en) Pharmaceutical compositions
AU2533495A (en) Pharmaceutical diketopiperazine compounds
AU2186797A (en) Pharmaceutically useful compounds
AU6904896A (en) Pharmaceutical compounds
AU3777897A (en) Pharmaceutical compositions
AU8591898A (en) Pharmaceutical compounds
GB9609976D0 (en) Pharmaceutical compounds
AU4925697A (en) Compounds
AU4330097A (en) Pharmaceutical compounds
GB9621789D0 (en) Pharmaceutical compounds
AU2531295A (en) Pharmaceutical composition
AU9343098A (en) Pharmaceutical composition
AU4169897A (en) Pharmaceutical compounds
AU6480299A (en) Pharmaceutical compounds
ZA979329B (en) Pharmaceutical compounds
AU4326197A (en) Pharmaceutical compositions
AU7546096A (en) Pharmaceutical compounds
GB9626151D0 (en) Pharmaceutical compounds
AU2087897A (en) Pharmaceutical compositions
AU4457597A (en) Pharmaceutical compositions
AU5184599A (en) Pharmaceutical compounds
AU5330198A (en) Therapeutic compounds